🇺🇸 FDA
Patent

US 8029808

Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality

granted A61KA61K2039/6043A61K31/135

Quick answer

US patent 8029808 (Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality) held by UNIVERSITY OF CONNECTICUT expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
UNIVERSITY OF CONNECTICUT
Grant date
Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K2039/6043, A61K31/135, A61K31/196, A61K31/277